Skip to main content
search

Schizophrenia Spectrum

Participate in a new clinical study aimed at evaluating a possible long-term treatment option for adults with schizophrenia.

Exploring New Possibilities for Schizophrenia Treatment

Schizophrenia is a chronic mental health condition that affects how a person thinks, feels, and behaves. Symptoms often include hallucinations, delusions, disorganized thinking, and impaired daily functioning. Managing this condition can be challenging, and current treatments may not always be effective for everyone.

Hightower Clinical is conducting an upcoming study focused on evaluating the long-term safety and tolerability of an investigational oral treatment for adults with schizophrenia. This study is designed to explore potential new options that may offer better symptom management for individuals living with schizophrenia. Participants in this study will play a key role in advancing mental health research and the development of future treatments.

Condition

Schizophrenia Spectrum

Current Status

Upcoming

Location

Oklahoma

Frequently Asked Questions

What type of treatment is being investigated in this study?

The study is investigating the long-term safety and tolerability of an investigational oral treatment for adults diagnosed with schizophrenia. This potential treatment is being tested to assess whether it can offer a possible new management option for schizophrenia symptoms.

How do I know if I qualify to participate in a study?

To determine eligibility for this study, individuals must meet specific criteria, including being an adult diagnosed with schizophrenia. Additional health factors may be considered to ensure the safety of participants.

What are the potential risks of participating in a clinical trial?

Clinical trials may carry certain risks, such as potential side effects of the investigational treatment. The research team will provide detailed information about possible risks and benefits before participation.

Close Menu